2017 Global Plasma Fractionation Industry Depth Research Report
- 886
- 15-Sep
- Medical Devices
- 120
- HCCResearch
-
Report Details
The report provides a comprehensive analysis of the Plasma Fractionation industry market by types, applications, players and regions. This report also displays the production, Consumption, revenue, Gross margin, Cost, Gross, market share, CAGR, and Market influencing factors of the Plasma Fractionation industry in USA, EU, China,India, Japan and other regions, and forecast to 2022, from 2017. Market Analysis by Players: CSL Ltd. Grifols S.A Baxalta Incorporated Octapharma AG Kedrion S.p.A China Biologic Products, Inc. Biotest AG LFB S.A Bio Product Laboratory Ltd. Sanquin Market Analysis by Regions: USA Europe China Japan India Market Anaysis by Types: Albumin: Immunoglobulin Intravenous Immunoglobulin Subcutaneous Immunoglobulin Others Coagulation Factor Concentrates: Factor VIII Factor IX Factor XIII Prothrombin Complex Concentrates: Von Willebrand Factor (VWF) Protease Inhibitors Other Plasma Fractionation Products Market Analysis by Applications: By Application: Neurology Immunology Haematology Haemato-oncology Pulmonology Rheumatology Critical Care Others By End User: Hospitals and Clinics Clinical Research Laboratories Academic Institutes
-
Table Of Content
1 Plasma Fractionation Market Overview 1.1 Product Overview of Plasma Fractionation 1.2 Classification of Plasma Fractionation by Product Category 1.2.1 Global Plasma Fractionation Sales and Growth (%) Comparison by Types (2012-2017) 1.2.2 Global Plasma Fractionation Sales Market Share (%) by Types in 2016 1.2.3 Type 1 1.2.4 Type 2 1.2.5 Type 3 1.2.6 Type 4 1.2.7 Type 5 1.3 Global Plasma Fractiona
-
Inquiry Before Buying
-
Request Sample